Evidence map›Paper›PMID 40369287›Full record

ReviewEye (London, England)2025

Retinal optical coherence tomography angiography (OCTA) biomarkers of cardiovascular disease: a review article.

Simon D Archambault, Omar Abu-Qamar, David Biery, Antonio Yaghy, Brittany Weber, Nadia K Waheed

Abstract readReview
In one paragraph

Review in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Iridology: Biological plausibility, clinical evidence, and implications for ophthalmic practice : A position paper of the Associazione Pazienti Malattie Oculari (APMO).Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Simon D Archambault *Department of Ophthalmology, Tufts Medical Center, Boston, MA, USA.ORCID http://orcid.org/0000-0001-9490-0103
Omar Abu-Qamar *Department of Ophthalmology, Tufts Medical Center, Boston, MA, USA.
David BieryDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Antonio YaghyDepartment of Ophthalmology, Tufts Medical Center, Boston, MA, USA.
Brittany WeberDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Nadia K WaheedDepartment of Ophthalmology, Tufts Medical Center, Boston, MA, USA. Nadia.Waheed@tuftsmedicine.org.ORCID http://orcid.org/0000-0002-8229-7519

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review article systematically assesses existing literature on studies employing retinal optical coherence tomography angiography (OCTA) metrics as surrogate biomarkers for cardiovascular disease. A comprehensive, literature review of published peer-reviewed research was conducted within PubMed utilizing the following medical subject headings (MeSH) terms: "optical coherence tomography", "cardiovascular diseases", "retina", and "retinal vessels". A total of 840 articles were reviewed and selectively filtered with ultimately 50 articles being included. This review article elucidates key findings, identifies limitations, and pinpoints gaps within these investigations. Additionally, this article delineates constraints related to OCTA technology and image processing that presently hinder the widespread adoption of this promising technology.

Indexed as

Cardiovascular DiseasesFluorescein AngiographyRetinal VesselsTomography, Optical CoherenceBiomarkersHumansBiomarkers

Identifiers

PMID40369287
PMCPMC12209461

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.